ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2018

A Dendritic Cell-Targeted Adenoviral Vector Facilitates Adaptive Immune Response Against Human Glioma Antigen (CMV-IE) and Prolongs Survival in a Human Glioma Tumor Model.

Julius W Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.